Craft

Bristol Myers Squibb

Stock Price

$51.7

2024-02-23

Market Capitalization

$103.1 B

2024-01-11

Revenue

$45 B

FY, 2023

Bristol Myers Squibb Summary

Company Summary

Overview
Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. It produces chemically synthesized drugs in the form of tablets, capsules, and injections for patients facing diseases in the areas of oncology, hematology, immunology, cardiovascular, and neuroscience. The company offers products such as Eliquis, Opdivo, Orencia, Sprycel, Reblozyl, Abecma, Opdualag, etc. BMS serves the healthcare industry.
Type
Public
Status
Active
Founded
1887
HQ
Princeton, NJ, US | view all locations
Website
https://www.bms.com/
Cybersecurity rating
ESG rating
60-79 out of 100|View all ESG data
Sectors

Key People

  • Chris Boerner

    Chris Boerner, Chief Executive Officer and Director

  • Sandra Leung

    Sandra Leung, Executive Vice President, General Counsel

  • David Elkins

    David Elkins, Executive Vice President and Chief Financial Officer

  • Samit Hirawat

    Samit Hirawat, Executive Vice President, Chief Medical Officer, Drug Development

Operating MetricsView all

Research and Development Centers

11
8.3%

FY, 2021

Phase II Trials Products (Oncology)

15
15.4%

FY, 2021

Phase III Trials Products (Oncology)

7
16.7%

FY, 2021

LocationsView all

75 locations detected

  • Princeton, NJ HQ

    United States

    Route 206 & Province Line Road

  • Atlanta, GA

    United States

    950 East Paces Ferry Rd NE

  • Bothell, WA

    United States

    1522 217th Pl SE

  • Cambridge, MA

    United States

    250 Water St, East Cambridge

  • Columbus, OH

    United States

    999 Polaris Pkwy #100

  • Devens, MA

    United States

    38 Jackson Rd

and 69 others

Bristol Myers Squibb Financials

Summary Financials

Revenue (FY, 2023)
$45.0B
Gross profit (FY, 2023)
$34.3B
Net income (FY, 2023)
$8.0B
Cash (FY, 2023)
$11.5B
Enterprise value
$131.4B

Footer menu